舒巴坦与黏菌素联合对耐黏菌素鲍曼不动杆菌的协同活性。 - Suppr

Suppr

超能文献

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

作者信息

Kempf Marie, Djouhri-Bouktab Lamia, Brunel Jean-Michel, Raoult Didier, Rolain Jean-Marc

出版信息

Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.

DOI:10.1016/j.ijantimicag.2011.10.001

PMID:22100281

Abstract

摘要

相似文献

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.

In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.

Int J Antimicrob Agents. 2010 Aug;36(2):191-2. doi: 10.1016/j.ijantimicag.2010.04.004. Epub 2010 May 26.

Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.

J Microbiol Immunol Infect. 2011 Oct;44(5):358-63. doi: 10.1016/j.jmii.2011.01.032. Epub 2011 Jan 20.

In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.

J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31.

In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S95-100.

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.

J Int Med Res. 2013 Dec;41(6):1830-7. doi: 10.1177/0300060513496172.

Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.

Int J Antimicrob Agents. 2004 May;23(5):487-93. doi: 10.1016/j.ijantimicag.2003.09.026.

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.

Int J Antimicrob Agents. 2007 Dec;30(6):537-40. doi: 10.1016/j.ijantimicag.2007.07.007. Epub 2007 Sep 11.

Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.

Chemotherapy. 2010;56(6):466-71. doi: 10.1159/000321015. Epub 2010 Nov 18.

In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.

J Med Assoc Thai. 2014 Mar;97 Suppl 3:S1-6.

引用本文的文献

The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.

Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.

Carbapenem-resistant and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches.

J Res Pharm Pract. 2024 Dec 23;13(2):33-40. doi: 10.4103/jrpp.jrpp_50_24. eCollection 2024 Apr-Jun.

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review.

Microorganisms. 2023 May 31;11(6):1459. doi: 10.3390/microorganisms11061459.

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.

Antimicrob Agents Chemother. 2022 May 17;66(5):e0214221. doi: 10.1128/aac.02142-21. Epub 2022 Mar 21.

Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.

Infect Dis Ther. 2021 Dec;10(4):2177-2202. doi: 10.1007/s40121-021-00541-4. Epub 2021 Oct 14.

Comparison of Intravenous Ampicillin-sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Randomized Open Label Trial.

Iran J Pharm Res. 2019 Fall;18(Suppl1):269-281. doi: 10.22037/ijpr.2019.112466.13775.

Multidrug-resistant strains with NDM-1: Molecular characterization and efficacy of meropenem-based combinations.

Exp Ther Med. 2019 Oct;18(4):2924-2932. doi: 10.3892/etm.2019.7927. Epub 2019 Aug 20.

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant .

Front Pharmacol. 2019 Jul 4;10:754. doi: 10.3389/fphar.2019.00754. eCollection 2019.

Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study.

Indian J Crit Care Med. 2018 Feb;22(2):67-77. doi: 10.4103/ijccm.IJCCM_302_17.

New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02480-17. Print 2018 Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验